Microvascular permeability change induced by platelet-activating factor is impaired in diabetic mice.
Fujii
E
E
Department of Pharmacology, Tokyo Women's Medical University, School of Medicine, 8-1 Kawada-cho, Tokyo, 162-8666, Japan.
Yoshioka
T
T
Wada
K
K
Ishida
H
H
Irie
K
K
Muraki
T
T
D000818:Animals; D001391:Azo Compounds / Q000493:pharmacokinetics; D002199:Capillary Permeability / Q000187:drug effects*; D004396:Coloring Agents / Q000493:pharmacokinetics; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy / Q000503:physiopathology*; D006001:Glycoconjugates / Q000032:analysis; D006146:Guanidines / Q000494:pharmacology / Q000627:therapeutic use; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D007213:Indomethacin / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008751:Methylene Blue / Q000494:pharmacology; D051379:Mice; D008817:Mice, Mutant Strains; D008833:Microcirculation / Q000187:drug effects*; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D010972:Platelet Activating Factor / Q000494:pharmacology*; D012867:Skin / Q000098:blood supply*; D013311:Streptozocin; D014343:Trypan Blue
D001391:Azo Compounds; D004396:Coloring Agents; D016861:Cyclooxygenase Inhibitors; D006001:Glycoconjugates; D006146:Guanidines; D007004:Hypoglycemic Agents; D007328:Insulin; D010972:Platelet Activating Factor; C009000:pontamine sky blue; D013311:Streptozocin; D019001:Nitric Oxide Synthase; D014343:Trypan Blue; C004479:pimagedine; D008751:Methylene Blue; D019331:NG-Nitroarginine Methyl Ester; D007213:Indomethacin